106 related articles for article (PubMed ID: 17257470)
41. Adverse reactions to rivastigmine in three cases of dementia.
Smith DJ; Yukhnevich S
Aust N Z J Psychiatry; 2001 Oct; 35(5):694-5. PubMed ID: 11551292
[No Abstract] [Full Text] [Related]
42. Evaluation of centrally acting cholinesterase inhibitor exposures in adults.
McCain KR; Sawyer TS; Spiller HA
Ann Pharmacother; 2007 Oct; 41(10):1632-7. PubMed ID: 17848422
[TBL] [Abstract][Full Text] [Related]
43. Student pharmacists: don't forget the product labeling.
Minor PD; Cook GE
J Am Pharm Assoc (2003); 2008; 48(6):696, 700. PubMed ID: 19019796
[No Abstract] [Full Text] [Related]
44. [Cardiac effects of cholinesterase inhibitors: a reason for restraint?].
Salarbaks AM; Boomkamp-Snoeren CM; van Puijenbroek E; Jansen PA; van Marum RJ
Tijdschr Gerontol Geriatr; 2009 Apr; 40(2):79-84. PubMed ID: 19472574
[TBL] [Abstract][Full Text] [Related]
45. Cholinergic balance in dementia with Lewy bodies: reversible worsening of Parkinsonism at rivastigmine dosage modulation.
Clerici F; Ratti PL; Pomati S; Maggiore L; Elia A; Mariani C
Neurol Sci; 2007 Oct; 28(5):282-4. PubMed ID: 17972045
[TBL] [Abstract][Full Text] [Related]
46. Comparing treatment effects in a clinical sample of patients with probable Alzheimer's disease treated with two different cholinesterase inhibitors.
Caffarra P; Vezzadini G; Copelli S; Dieci F; Messa G; Nonis E; Venneri A
Acta Biomed; 2007; 78(1):16-21. PubMed ID: 17687812
[TBL] [Abstract][Full Text] [Related]
47. Safety and tolerability of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients.
Senanarong V; Poungvarin N; Phanthumchinda K; Thavichachart N; Chankrachang S; Praditsuwan R; Nidhinandana S
J Med Assoc Thai; 2009 Mar; 92 Suppl 2():S12-8. PubMed ID: 19562980
[TBL] [Abstract][Full Text] [Related]
48. Rivastagmine-induced agitation following transient recollection of autobiographical memory.
Caffarra P; Majer S; Godani M; Paolello P
Neurol Sci; 2001 Jun; 22(3):279-80. PubMed ID: 11731885
[No Abstract] [Full Text] [Related]
49. A rivastigmine-precipitated manic episode in a patient with Alzheimer-type dementia.
Tseng WS; Tzeng NS
Int Psychogeriatr; 2012 Oct; 24(10):1697-9. PubMed ID: 22717054
[TBL] [Abstract][Full Text] [Related]
50. Rivastigmine in Parkinson's disease dementia.
Chitnis S; Rao J
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):941-55. PubMed ID: 19619073
[TBL] [Abstract][Full Text] [Related]
51. Mania after administration of cholinesterase inhibitors in patients with dementia and comorbid bipolar disorder: two case reports.
Ehrt U; Fritze F; Aarsland D
J Clin Psychopharmacol; 2011 Apr; 31(2):254-6. PubMed ID: 21364344
[No Abstract] [Full Text] [Related]
52. Prolonged QT interval with rivastigmine.
Walsh E; Dourish J
Br J Psychiatry; 2002 May; 180():466. PubMed ID: 11983648
[No Abstract] [Full Text] [Related]
53. [Cholinesterase inhibitors in Alzheimer disease; preliminary recommendations for the practice].
Van Zwieten-Boot BJ; Lekkerkerker JF
Ned Tijdschr Geneeskd; 1998 Nov; 142(48):2644-5; author reply 2645-6. PubMed ID: 10028368
[No Abstract] [Full Text] [Related]
54. Unsubstantiated superiority claims for rivastigmine tartrate.
Shah SK; Krueger PM
J Am Osteopath Assoc; 2006 Oct; 106(10):589-90; author reply 590. PubMed ID: 17122027
[No Abstract] [Full Text] [Related]
55. Atrial flutter in a patient with Alzheimer dementia treated by rivastigmine.
Hsu YC; Chao CY; Chang HA; Hwang SY; Tzeng NS
J Neuropsychiatry Clin Neurosci; 2013; 25(2):E25-6. PubMed ID: 23686050
[No Abstract] [Full Text] [Related]
56. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
57. Acetylcholinesterase inhibitors in assisted living: patterns of use and association with retention.
Rosenblatt A; Samus QM; Onyike CU; Baker AS; McNabney M; Mayer LS; Brandt J; Lyketsos CG
Int J Geriatr Psychiatry; 2008 Feb; 23(2):178-84. PubMed ID: 17676652
[TBL] [Abstract][Full Text] [Related]
58. Adherence to cholinesterase inhibitors in patients with Alzheimer's disease.
Blais L; Kettani FZ; Perreault S; Leroux JC; Forget A; Kergoat MJ
J Am Geriatr Soc; 2009 Feb; 57(2):366-8. PubMed ID: 19207161
[No Abstract] [Full Text] [Related]
59. Cholinergic modulation of MEG resting-state oscillatory activity in Parkinson's disease related dementia.
Bosboom JL; Stoffers D; Stam CJ; Berendse HW; Wolters ECh
Clin Neurophysiol; 2009 May; 120(5):910-5. PubMed ID: 19386543
[TBL] [Abstract][Full Text] [Related]
60. Pharmacokinetics of a rivastigmine transdermal patch formulation in healthy volunteers: relative effects of body site application.
Lefèvre G; Sedek G; Huang HL; Saltzman M; Rosenberg M; Kiese B; Fordham P
J Clin Pharmacol; 2007 Apr; 47(4):471-8. PubMed ID: 17389556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
